Atrys Health, S.A. (BME:ATRY)

Spain flag Spain · Delayed Price · Currency is EUR
3.390
+0.020 (0.59%)
Oct 28, 2025, 1:41 PM CET
0.59%
Market Cap248.87M
Revenue (ttm)226.24M
Net Income (ttm)-24.59M
Shares Out75.87M
EPS (ttm)-0.32
PE Ration/a
Forward PE218.67
Dividendn/a
Ex-Dividend Daten/a
Volume6,406
Average Volume135,482
Open3.390
Previous Close3.370
Day's Range3.370 - 3.410
52-Week Range2.480 - 3.670
Beta0.64
RSI61.62
Earnings DateDec 23, 2025

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 2,045
Stock Exchange Madrid Stock Exchange
Ticker Symbol ATRY
Full Company Profile

Financial Performance

In 2024, Atrys Health's revenue was 218.10 million, an increase of 5.82% compared to the previous year's 206.10 million. Losses were -31.77 million, -30.30% less than in 2023.

Financial Statements

News

There is no news available yet.